Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12930)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2016 (publication date) through Apr 17, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Song JL, Gao W, Zhong Y, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG, Jiang L, Yang J. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation. World J Gastroenterol 2016; 22(6): 2133-2141 [PMID: 26877618 DOI: 10.3748/wjg.v22.i6.2133] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Song JL, Gao W, Zhong Y, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Wu H, Xu MQ, Chen ZY, Wei YG, Jiang L, Yang J. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation. World J Gastroenterol 2016; 22(6): 2133-2141 [PMID: 26877618 DOI: 10.3748/wjg.v22.i6.2133] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i6/2133.htm |
| Number | Citing Articles |
| 1 |
Thomas Jouve, Johan Noble, Lionel Rostaing, Paolo Malvezzi. An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization. Expert Opinion on Drug Safety 2019; 18(4): 285 doi: 10.1080/14740338.2019.1599858
|
| 2 |
Pan Kun-ming, Chen Can, Xu Qing, Wu Wei, Lv Qian-zhou, Li Xiao-yu. Calcineurin inhibitor–associated new-onset diabetes mellitus in chronic kidney disease treatment: a 4-year single-center cross-sectional study in China. European Journal of Clinical Pharmacology 2021; 77(7): 961 doi: 10.1007/s00228-021-03095-z
|
| 3 |
Xiao-fu Xiong, Ding-ding Chen, Huai-jun Zhu, Wei-hong Ge. Prognostic Value of Endogenous and Exogenous Metabolites in Liver Transplantation. Biomarkers in Medicine 2020; 14(12): 1165 doi: 10.2217/bmm-2020-0073
|
| 4 |
Zhen Zhang, Jianyun Sun, Meng Guo, Xuemin Yuan. Progress of new-onset diabetes after liver and kidney transplantation. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1091843
|
| 5 |
Longbo Wang, Xiyang Sheng, Gengyuan Shi, Yongzhao Li, Dongdong Wang, Wei Wang, Chen Mi, Siyang Wang, Yongyue Du, Hanteng Yang. Immunometabolic remodeling: new perspectives and strategies for liver transplantation. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1776694
|
| 6 |
Tianwei Lan, Xin Zhang, Qian Yu. Anaemia associated with Tacrolimus: A case report and literature review. Journal of Clinical Pharmacy and Therapeutics 2020; 45(6): 1497 doi: 10.1111/jcpt.13238
|
| 7 |
Shingo Shimada, Katsunori Miyake, Deepak Venkat, Humberto Gonzalez, Dilip Moonka, Atsushi Yoshida, Marwan Abouljoud, Shunji Nagai. Clinical characteristics of new‐onset diabetes after liver transplantation and outcomes. Annals of Gastroenterological Surgery 2024; 8(3): 383 doi: 10.1002/ags3.12775
|
| 8 |
Mark W. Russo, William Wheless, Dionisios Vrochides. Management of long-term complications from immunosuppression. Liver Transplantation 2024; 30(6): 647 doi: 10.1097/LVT.0000000000000341
|
| 9 |
Shintaro Yagi, Toshimi Kaido, Taku Iida, Atsushi Yoshizawa, Hideaki Okajima, Shinji Uemoto. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function. Surgery Today 2017; 47(6): 733 doi: 10.1007/s00595-016-1444-z
|
| 10 |
Rohit Mehtani, Jaya Agarwal, Sanjiv Saigal. Fundamentals of Transplant Hepatology. 2026; : 789 doi: 10.1007/978-981-95-2624-6_38
|
| 11 |
Johan Noble, Florian Terrec, Paolo Malvezzi, Lionel Rostaing. Adverse effects of immunosuppression after liver transplantation. Best Practice & Research Clinical Gastroenterology 2021; : 101762 doi: 10.1016/j.bpg.2021.101762
|
| 12 |
Chun Xu, Hai-Ying Xiao, Bo-Yu Zhu, Fei Gao, Min Ran, Yi Wang, Hao-Yan Li. Tacrolimus induces insulin receptor substrate 1 hyperphosphorylation and inhibits mTORc1/S6K1 cascade in HL7702 cells. World Journal of Diabetes 2025; 16(2): 97910 doi: 10.4239/wjd.v16.i2.97910
|
| 13 |
Eloi Chevallier, Thomas Jouve, Lionel Rostaing, Paolo Malvezzi, Johan Noble. pre-existing diabetes and PTDM in kidney transplant recipients: how to handle immunosuppression. Expert Review of Clinical Pharmacology 2021; 14(1): 55 doi: 10.1080/17512433.2021.1851596
|
| 14 |
Abbie D. Leino, Manjunath P. Pai. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clinical Pharmacokinetics 2020; 59(11): 1317 doi: 10.1007/s40262-020-00923-w
|
| 15 |
Chih-Yang Hsiao, Ming-Chih Ho, Cheng-Maw Ho, Yao-Ming Wu, Po-Huang Lee, Rey-Heng Hu. Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation. Journal of Personalized Medicine 2021; 11(2): 90 doi: 10.3390/jpm11020090
|
| 16 |
Mateo Chvatal‐Medina, Yakun Li, Adrian Post, Margery A. Connelly, Han Moshage, Stephan J. L. Bakker, Vincent E. de Meijer, Hans Blokzijl, Robin P. F. Dullaart. Triacylglycerol‐Based Insulin Resistance Indices and Post‐Transplantation Diabetes Mellitus After Liver Transplantation. Lipids 2026; doi: 10.1002/lipd.70048
|
| 17 |
Prani Paka, Sarah R Lieber, Ruth-Ann Lee, Chirag S Desai, Robert E Dupuis, Alfred Sidney Barritt. Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review. World Journal of Transplantation 2018; 8(3): 75-83 doi: 10.5500/wjt.v8.i3.75
|
| 18 |
Antônio Ricardo Cardia Ferraz de Andrade, Helma P. Cotrim, Paulo L. Bittencourt, Carolina G. Almeida, Ney Christian Amaral Boa Sorte. Nonalcoholic steatohepatitis in posttransplantation liver: Review article. Revista da Associação Médica Brasileira 2018; 64(2): 187 doi: 10.1590/1806-9282.64.02.187
|
| 19 |
Aloysious D. Aravinthan, Waleed Fateen, Adam C. Doyle, Suresh V. Venkatachalapathy, Assaf Issachar, Zita Galvin, Gonzalo Sapisochin, Mark S. Cattral, Anand Ghanekar, Ian D. McGilvray, Markus Selzner, David R. Grant, Nazia Selzner, Leslie B. Lilly, Eberhard L. Renner, Mamatha Bhat. The Impact of Preexisting and Post-transplant Diabetes Mellitus on Outcomes Following Liver Transplantation. Transplantation 2019; 103(12): 2523 doi: 10.1097/TP.0000000000002757
|
| 20 |
Sonja Beckmann, Gerda Drent, Todd Ruppar, Nataša Nikolić, Sabina De Geest. Body Weight Parameters are Related to Morbidity and Mortality After Liver Transplantation: A Systematic Review and Meta-analysis. Transplantation 2019; 103(11): 2287 doi: 10.1097/TP.0000000000002811
|
| 21 |
Jongman Kim, Jae-Won Joh, Kwang-Woong Lee, Dong Lak Choi, Hee-Jung Wang. Safety and efficacy of early corticosteroid withdrawal in liver transplant recipients: A randomized controlled trial. Annals of Hepato-Biliary-Pancreatic Surgery 2024; 28(2): 238 doi: 10.14701/ahbps.23-129
|
| 22 |
Mariana Baldini Campos, Cínthia Minatel Riguetto, Ilka de Fátima Santana Ferreira Boin, Arnaldo Moura. Risk factors associated with diabetes after liver transplant. Archives of Endocrinology and Metabolism 2022; doi: 10.20945/2359-3997000000447
|
| 23 |
Rohit Mehtani, Sanjiv Saigal. Long Term Complications of Immunosuppression Post Liver Transplant. Journal of Clinical and Experimental Hepatology 2023; 13(6): 1103 doi: 10.1016/j.jceh.2023.06.007
|
| 24 |
Tommaso Maria Manzia, Roberta Angelico, Luca Toti, Cristina Angelico, Claudia Quaranta, Alessandro Parente, Francesca Blasi, Samuele Iesari, Daniele Sforza, Leonardo Baiocchi, Jan Lerut, Giuseppe Tisone. Longterm Survival and Cost‐Effectiveness of Immunosuppression Withdrawal After Liver Transplantation. Liver Transplantation 2018; 24(9): 1199 doi: 10.1002/lt.25293
|
| 25 |
Chengbo Ai, Jiulin Song, Chi Yuan, Gang Xu, Jian Yang, Tao Lv, Shuguang Jin, Hong Wu, Bo Xiang, Jiayin Yang. Prediction model of the T cell-mediated rejection after liver transplantation in children and adults: A case-controlled study. International Journal of Surgery 2025; 111(4): 2827 doi: 10.1097/JS9.0000000000002279
|
| 26 |
Poh Seng Tan, Mark D. Muthiah, Tsingyi Koh, Yee Leong Teoh, Albert Chan, Alfred Kow, Qishi Zheng, Choon Hyuck David Kwon, Guan Huei Lee, Cosmas Rinaldi A. Lesmana, Vanessa de Villa, James Fung, Kieron Lim. Asian Liver Transplant Network Clinical Guidelines on Immunosuppression in Liver Transplantation. Transplantation 2019; 103(3): 470 doi: 10.1097/TP.0000000000002532
|
| 27 |
Ruiping Bai, Rui An, Siyu Chen, Wenkang Ding, Mengwen Xue, Ge Zhao, Qingyong Ma, Xin Shen. Risk factors and prediction score for new‐onset diabetes mellitus after liver transplantation. Journal of Diabetes Investigation 2024; 15(8): 1105 doi: 10.1111/jdi.14204
|
| 28 |
Ali R Chaitou, Surbhi Valmiki, Mrinaal Valmiki, Maria Zahid, Mohamed A Aid, Peter Fawzy, Safeera Khan. New-Onset Diabetes Mellitus (NODM) After Liver Transplantation (LT): The Ultimate Non-diabetogenic Immunosuppressive Therapy. Cureus 2022; doi: 10.7759/cureus.23635
|
| 29 |
Venkat Bhat, Mahmood Tazari, Kymberly D. Watt, Mamatha Bhat. New-Onset Diabetes and Preexisting Diabetes Are Associated With Comparable Reduction in Long-Term Survival After Liver Transplant: A Machine Learning Approach. Mayo Clinic Proceedings 2018; 93(12): 1794 doi: 10.1016/j.mayocp.2018.06.020
|
| 30 |
Chang Seong Kim, Ansuja Pulickal Mathew, Arathy Vasukutty, Saji Uthaman, Soo Yeon Joo, Eun Hui Bae, Seong Kwon Ma, In-Kyu Park, Soo Wan Kim. Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-00857-w
|
| 31 |
Yip Han Chin, Hon Qin Marcus Tan, Cheng Han Ng, Darren Jun Hao Tan, Snow Yunni Lin, Daniel Q. Huang, Chin Meng Khoo, Mark Dhinesh Muthiah. A Time-Based Meta-Analysis on the Incidence of New Onset Diabetes after Liver Transplantation. Journal of Clinical Medicine 2021; 10(5): 1045 doi: 10.3390/jcm10051045
|